High vs Low Molecular Weight HA in Skin Boosters: What It Means for Clinical Results

Most practitioners know that hyaluronic acid is the active ingredient in skin booster treatments. Fewer know that not all HA is clinically equivalent — and that the molecular weight of the HA in a product is one of the most important determinants of how that product will behave in tissue, what biological effects it will produce, and which patient profile and treatment goal it is best suited to.

Molecular weight is not a marketing variable. It is a physical chemistry parameter that directly governs how HA chains interact with cell surface receptors, how deeply they penetrate tissue, how much water they bind and retain, and how powerfully they stimulate fibroblasts to produce collagen and endogenous HA. A product formulated with very high molecular weight HA will produce a different clinical effect than one formulated with very low molecular weight HA — even if both are injected at the same depth, in the same zone, in the same patient, by the same practitioner.

This guide covers the science of HA molecular weight, the clinical implications of different MW profiles in skin booster products, how Korean manufacturers have applied this science in product development, and how to use this knowledge to make better product selection decisions for your patients. It is part of Celmade's Skin Booster cluster — for the clinical overview, see the Complete Practitioner's Guide to Skin Boosters.

What Is Molecular Weight and Why Does It Matter for HA?

Molecular weight (MW) is a measure of the size of a molecule — expressed in Daltons (Da) or kilodaltons (kDa). One Dalton is approximately the mass of a single hydrogen atom. A HA molecule's MW is determined by the number of repeating disaccharide units it contains: a short HA chain of 100 units weighs approximately 40 kDa; a very long chain of 25,000 units weighs approximately 10,000 kDa (10 MDa).

In practical terms, MW determines three fundamental properties of an HA molecule in biological tissue:

•        Physical size and tissue penetration: Smaller molecules diffuse more readily through tissue. Very low MW HA fragments (< 50 kDa) penetrate cell membranes and reach intracellular compartments; high MW HA (> 1,000 kDa) remains largely in the extracellular matrix.

•        Water-holding capacity: Longer chains have more hydroxyl groups available for hydrogen bonding with water molecules. High MW HA holds more water per molecule and creates a more sustained hydration depot.

•        Biological signalling: HA fragments of different sizes bind to different cell surface receptors and trigger different biological responses. This receptor-binding specificity is the most clinically important aspect of HA molecular weight — it determines whether the injected HA stimulates regeneration, suppresses inflammation, or simply provides passive hydration.

The Receptor Biology: How Different MW HA Signals to Cells

HA does not act as a passive filler material — it is a signalling molecule that interacts with specific cell surface receptors to trigger biological responses. The key receptors relevant to skin booster treatment are:

CD44 — The Primary HA Receptor

CD44 is the most widely expressed HA receptor in skin tissue, found on fibroblasts, keratinocytes, and immune cells. CD44 binds preferentially to high and medium MW HA (> 100 kDa). When CD44 is engaged by large HA molecules, the signalling cascade stimulates:

•        Fibroblast survival and proliferation — maintaining the cell population responsible for collagen and elastin synthesis

•        HA synthase expression — driving endogenous HA production

•        Anti-apoptotic signalling — protecting fibroblasts from programmed cell death under oxidative or mechanical stress

This means that high MW HA injected into the dermis primarily signals through CD44 to maintain fibroblast health, support the dermal cell population, and stimulate endogenous HA production. The primary clinical effect is structural and hydration-supporting — not acute fibroblast proliferation.

RHAMM (Receptor for Hyaluronan-Mediated Motility)

RHAMM (also known as HMMR) binds preferentially to low MW HA fragments (< 500 kDa, particularly < 200 kDa). When RHAMM is activated by small HA chains:

•        Fibroblast motility increases — fibroblasts migrate to the injection site and surrounding tissue

•        Proliferation signalling activates — fibroblast division and population expansion is directly stimulated

•        Wound healing pathways upregulate — the same pathways active in tissue repair are engaged by small HA fragments

This means that low MW HA acts more directly as a biological trigger for fibroblast activity. The primary clinical effect is acute regenerative stimulation — collagen and elastin production — rather than passive hydration.

TLR4 — The Inflammatory Receptor (Very Low MW Only)

Very low MW HA fragments (< 10 kDa — the smallest chains produced by enzymatic degradation) also bind to Toll-Like Receptor 4 (TLR4), a pattern recognition receptor in the innate immune system. TLR4 activation by these fragments triggers pro-inflammatory signalling. This inflammatory activity is not desirable in aesthetic biorevitalisation — it explains why degradation products of HA (produced when tissue-resident hyaluronidases break down injected HA) can sometimes cause mild transient inflammation at injection sites, and why formulations using extremely fragmented HA for direct injection must be used cautiously.

For the full receptor biology, see Stern et al. (2006) in the European Journal of Cell Biology, which provides a comprehensive review of HA-receptor interactions and their biological consequences at different molecular weights.

Clinical Properties by Molecular Weight Tier

The following breakdown covers the four main MW tiers encountered in skin booster products, from very low to very high:

Master Comparison: Molecular Weight Properties at a Glance

Translating MW Science into Product Selection Decisions

Understanding molecular weight allows practitioners to move beyond brand recognition in product selection and make evidence-based choices based on the specific clinical goal and patient profile:

How Korean Manufacturers Apply Molecular Weight Science

The Korean medical aesthetics industry has been among the most scientifically rigorous in applying MW science to product development. Several innovations worth understanding:

Controlled Depolymerisation

Korean manufacturers have developed controlled enzymatic and chemical depolymerisation processes that produce HA fragments of precisely defined molecular weight ranges — allowing formulation of products with specific MW profiles rather than broad MW distributions. This precision formulation is what enables dual MW products with genuinely distinct high and low MW fractions rather than a broad mid-range distribution.

MW-Optimised Stabilisation

Stabilising low MW HA without converting it to a crosslinked filler is a manufacturing challenge — shorter chains are more susceptible to rapid enzymatic degradation once injected. Korean manufacturers have developed light stabilisation technologies (not full BDDE crosslinking) that extend the tissue residence time of low MW HA without eliminating its free-chain biological activity. This allows low MW HA to remain in the tissue long enough to exert its full fibroblast stimulation effect before being metabolised.

HA + PN Hybrid Formulations

The combination of low MW HA with polynucleotides (PN) in a single product represents the most advanced application of biorevitalisation science currently available to aesthetic practitioners. Low MW HA provides direct fibroblast stimulation via RHAMM; PN provides adenosine A2A receptor-mediated growth factor signalling. The two mechanisms operate through completely different receptor pathways, producing a genuinely additive rather than merely cumulative biological effect.

Celmade's skin booster range includes CE-marked Korean HA skin boosters formulated across the MW spectrum — from high MW products for dehydrated skin to advanced dual MW and HA+PN hybrid products for regenerative protocols. For PN-specific products, see the PDRN and PN range.

How to Read a Skin Booster Product Data Sheet for MW Information

When evaluating a new skin booster product, the following information points should be present in the technical documentation:

•        HA molecular weight or MW range: Should be stated in kDa or Da. If only 'HA concentration' is stated without MW information, the product documentation is incomplete for clinical decision-making purposes.

•        Single or dual MW formulation: Should be explicitly stated. If the product contains both high and low MW fractions, the approximate MW of each component should be documented.

•        Crosslinking status: Is the HA free, lightly stabilised, or crosslinked? This affects both the biological activity and the mechanical behaviour. Free HA is most biologically active; crosslinked HA behaves as a filler.

•        HA concentration (mg/ml): The concentration combined with MW determines the total biological load per millilitre. A high MW product at high concentration delivers a large hydration depot; a low MW product at high concentration delivers a high fibroblast stimulation stimulus.

•        Additional active ingredients: PN content (mg/ml), amino acids, vitamins, antioxidants, or other actives present. These modify the biological effect profile beyond the HA MW profile alone.

The Hydration-Regeneration Spectrum: A Clinical Decision Framework

Thinking about HA MW in terms of a clinical spectrum — from hydration-dominant (high MW) to regeneration-dominant (low MW) — provides a practical mental model for product selection:

Key Takeaways

•        Molecular weight determines clinical effect — not just the HA concentration or brand name. Two products both labelled '20 mg/ml HA skin booster' will produce different clinical outcomes if one uses high MW HA and the other uses low MW HA.

•        High MW HA: hydration and water retention — acts primarily through CD44 to maintain the dermal water depot and support fibroblast survival. Best for dehydration-dominant profiles.

•        Low MW HA: regeneration and fibroblast proliferation — acts primarily through RHAMM to directly stimulate fibroblast division and collagen induction. Best for early ageing and texture improvement.

•        Dual MW products do both — they are the most clinically versatile category, combining hydration and regeneration in a single product. Profhilo's innovation was demonstrating this principle; Korean manufacturers have since produced a range of dual MW formulations applying the same concept.

•        Very low MW HA (< 50 kDa) stimulates strongly but also activates inflammation — appropriate for regenerative protocols in patients with significant collagen deficit, with the expectation of more post-injection reactivity.

•        Korean manufacturers have led MW-science-based product development — applying controlled depolymerisation, MW-optimised stabilisation, and HA+PN hybrid formulations to produce CE-marked products available through Celmade's skin booster and PDRN/PN ranges.

•        Ask for MW information when evaluating any new skin booster product — a supplier unable to provide HA MW data cannot adequately support your clinical decision-making.

Explore Celmade's skin booster range — including single and dual MW Korean HA formulations — and the PDRN and PN range for the full regenerative end of the spectrum. For related cluster guides, see: Complete Skin Boosters Practitioners Guide, Profhilo vs Korean Skin Boosters, Biorevitalisation Patient Selection, and Best Skin Boosters for Under-Eye Rejuvenation.

Frequently Asked Questions

Does higher molecular weight mean a better skin booster?

Not necessarily — it means a different skin booster. High MW HA creates a stronger water-holding depot and produces sustained hydration. Low MW HA provides stronger fibroblast stimulation and collagen induction. The 'better' product depends on the clinical goal: for dehydrated skin in a younger patient, high MW may produce the most visible immediate result; for a patient with significant collagen deficit and skin quality decline, low MW or dual MW will produce the most meaningful long-term improvement. Neither is universally superior — they address different mechanisms.

What is the molecular weight of Profhilo?

Profhilo contains two HA components: H-HA at approximately 1,100 kDa (very high molecular weight) and L-HA at approximately 20 kDa (very low molecular weight), combined through thermal hybridisation without chemical crosslinker. The H-HA provides the hydration depot; the L-HA provides the fibroblast stimulation. The dual MW principle is Profhilo's defining scientific contribution to the skin booster category. Korean dual MW products apply the same principle using different MW combinations and formulation processes.

Is low MW HA safe to inject?

Yes — low MW HA (50–500 kDa) is safe for intradermal injection. The RHAMM-mediated fibroblast stimulation it produces is a beneficial biological effect. Very low MW HA (< 50 kDa) can produce more pronounced post-injection reactivity due to TLR4 activation, which manifests as mild transient redness and swelling rather than a safety concern. The safety profile of HA products at all molecular weights is well established — all degrade into glucuronic acid and N-acetylglucosamine, which are natural metabolic products.

How do I find out the molecular weight of a Korean skin booster product?

Request the technical datasheet or Summary of Product Characteristics (SPC) from your supplier. CE-marked Korean skin boosters must have full product documentation available. The MW should be stated in the product documentation as a numerical value in kDa or Da, or as a range. Celmade provides full product documentation including MW information for all skin booster products in our skin booster range. If a product's MW information is not readily available, this is a documentation gap worth resolving before clinical use.

Should I use different MW products for different patients or use one product for all?

Ideally, you should have at least two product tiers available: a standard HA skin booster (high to mid MW) for dehydrated and hydration-priority patients, and a dual MW or HA+PN hybrid product for early ageing and regeneration-priority patients. A single product applied universally will be suboptimal for a proportion of your patients. The most sophisticated practices use three product tiers — standard HA (hydration), dual MW HA (balanced), and PN/PDRN (pure regeneration) — allowing precise matching of product to patient profile at consultation.